First Trimester Screening is a crucial component of prenatal care for expectant mothers in Burlington and beyond. This screening is typically conducted between weeks 11 and 14 of pregnancy to assess the risk of certain chromosomal conditions in the fetus, such as Down syndrome. It involves a combination of ultrasound and blood tests to gather important information about the baby's development and health. During the ultrasound portion of the screening, the healthcare provider will measure the thickness at the back of the baby's neck. This measurement, known as nuchal translucency, can provide insights into the likelihood of chromosomal abnormalities. Additionally, a blood test is performed to analyze specific proteins and hormones that further contribute to the assessment. By combining the results of the ultrasound and blood tests, healthcare providers can offer expectant parents valuable information about the potential health of their baby. First Trimester Screening is an essential step in prenatal care as it allows healthcare providers to identify any potential risks early in the pregnancy. This information can help parents make informed decisions about further testing or interventions, if necessary, and better prepare for the arrival of their child. By understanding the purpose and process of First Trimester Screening, parents-to-be in Burlington can take proactive steps towards ensuring the health and well-being of their baby.